GRCL
Price:
$10.25
Market Cap:
$7.01B
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult B cell acute lymphoblastic leukemia (B-ALL), as well as in preclinical stage for the treatment of relapsed or refractory (r/r) B cell non-Hodgkin's lymphoma (B-NHL); and GC027, a TruUCAR-...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
NASDAQ
Ticker
GRCL
According to Gracell Biotechnologies Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Gracell Biotechnologies Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), GRCL's Dividend Yield was at its highest in in the December 2019 quarter at 0%. The Dividend Yield was at its lowest in in the December 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Gracell Biotechnologies Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
The current Dividend Yield of Gracell Biotechnologies Inc. (GRCL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Gracell Biotechnologies Inc.’s Dividend Yield is less than Theseus Pharmaceuticals, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Erasca, Inc. (0%), less than NextCure, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Coherus BioSciences, Inc. (0%), less than Icosavax, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Decibel Therapeutics, Inc. (0%), less than Blueprint Medicines Corporation (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $181.50M | |
0% | $349.21M | |
0% | $264.42M | |
0% | $807.96M | |
0% | $39.73M | |
0% | $93.74M | |
0% | $8.20M | |
0% | $71.07M | |
0% | $107.81M | |
0% | $549.60M | |
0% | $161.36M | |
0% | $133.38M | |
0% | $312.42M | |
0% | $109.78M | |
0% | $24.78M | |
0% | $142.86M | |
0% | $769.04M | |
0% | $1.25B | |
0% | $123.37M | |
0% | $5.47B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gracell Biotechnologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gracell Biotechnologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Gracell Biotechnologies Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Gracell Biotechnologies Inc. (GRCL)?
What is the highest Dividend Yield for Gracell Biotechnologies Inc. (GRCL)?
What is the 3-year average Dividend Yield for Gracell Biotechnologies Inc. (GRCL)?
What is the 5-year average Dividend Yield for Gracell Biotechnologies Inc. (GRCL)?
How does the current Dividend Yield for Gracell Biotechnologies Inc. (GRCL) compare to its historical average?